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Heterotrimeric guanine nucleotide-binding regula- 
tory proteins (G proteins)  consist  of a nucleotide-bind- 
ing (Y subunit  and a high-affinity complex  of @ and y 
subunits.  There is molecular heterogeneity of @ and y, 
but  the significance of this diversity is poorly  under- 
stood. Different G protein @ and y subunits have been 
expressed both singly and  in  combinations in Sf9 cells. 
Although  expression  of  individual  subunits is achieved 
in all cases, By subunit activity (support of pertussis 
toxin-catalyzed ADP-ribosylation  of rGial) is detected 
only when j3 and y are expressed concurrently. Of the 
six combinations of By tested (Dl or with yl, yz, or 
y3), only one, Bzyl, failed to  generate a functional  com- 
plex. Each  of the  other five complexes  has  been purified 
by subunit exchange chromatography using G,-aga- 
rose as the  chromatographic matrix. We have detected 
differences in  the abilities of the  purified  proteins to 
support  ADP-ribosylation  of Gial; these differences are 
attributable  to  the y component  of  the  complex. When 
assayed for  their ability to  inhibit  calmodulin-stimu- 
lated type-I adenylylcyclase activity or  to  potentiate 
G,-stimulated type-I1 adenylylcyclase, recombinant 
Btyl and  transducin @y are approximately 10 and 20 
times less potent, respectively, than the other com- 
plexes examined. Prenylation andlor  further carboxyl- 
terminal  processing of y are not required  for  assembly 
of the By subunit complex but are indispensable for 
high affinity interactions of @y with either G protein a 
subunits or adenylylcyclases. 
Guanine nucleotide-binding regulatory proteins (G pro- 
teins)’  transmit signals that  are generated by a large number 
of plasma membrane-bound  receptors to intracellular effector 
* This work  was supported in  part by National  Institutes of Health 
Grants GM34497, GM34236, and GM39867, American Cancer Soci- 
ety Grant BE30N, the Perot Family Foundation, the Lucille P. 
Markey Charitable Trust,  and  the Raymond and Ellen Willie Chair 
of Molecular Neuropharmacology. The  costs of publication of  this 
article were defrayed in part by the payment of page charges. This 
article must  therefore be hereby marked “advertisement” in accord- 
ance with 18 U.S.C. Section 1734 solely to indicate this fact. 
5 Recipient of a Howard Hughes Medical Institute predoctoral 
training award. 
** Established  Investigator of the American Heart Association. 
$$ To whom correspondence  should be addressed Dept. of Phar- 
macology, University of Texas  Southwestern Medical Center, 5323 
Harry  Hines Blvd., Dallas, TX 75235. 
The abbreviations used are:  G protein, guanine  nucleotide-bind- 
ing regulatory protein; the  short form of G,, expressed in E. 
coli; rG,,,,, the a subunit of Gi expressed in E. coli; Go,, the 01 subunit 
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enzymes and ion channels (reviewed in Refs. 1-3). G  proteins 
are heterotrimers, composed of a  guanine nucleotide-binding 
a subunit (molecular mass of 39-46 kDa) and a tight complex 
of P (37 kDa) and y (8-10 kDa) subunits. The signaling 
process involves the sequential  formation and dissociation of 
complexes between G  protein OL and Py subunits  and between 
G  protein subunits  and both  upstream  (receptor) and down- 
stream (effector) elements. This process is driven by the 
binding of agonist ligands to receptors and by the binding and 
hydrolysis of GTP by the G  protein a subunit (1-4). Receptors 
catalyze exchange of GDP for GTP  on G  protein a subunits; 
activated GTP-bound a then dissociates from the receptor 
and By, and  both appear capable of regulating downstream 
effector molecules. This active state is transient, however, 
and decays because of the intrinsic GTPase activity of the a 
subunit.  GDP-bound a has a high affinity for fly, reassociates 
to form a heterotrimer, and is thus available for further 
stimulation by receptors. 
Most interest  in G proteins has been focused on  their a 
subunits, since these  proteins bind and hydrolyze GTP  and 
most obviously regulate the activity of the best-studied effec- 
tors (cyclic GMP phosphodiesterase and adenylylcyclase). 
Much less is known about the  structure  and function of by. 
The Py subunit complex is essential for functional  interac- 
tions of G protein LY subunits with receptors (5-7). Recent 
data also suggest that  the interaction of By with receptors is 
important for agonist-dependent receptor phosphorylation, 
suggesting an  important role for Py in desensitization (8). By 
subunits can also regulate effector molecules. Genetic studies 
of Saccharomyces cerevisiae indicate that Py carries the signal 
from pheromone receptors to  an  as yet unidentified down- 
stream effector (9-11). Py can also regulate adenylylcyclase 
activity, and the effects of the protein complex differ for 
individual forms of the enzyme. Whereas by inhibits type-I 
adenylylcyclase when stimulated by either GB, or calmodulin, 
Py greatly potentiates  the stimulatory effect of  G,, on either 
type-I1 or type-IV adenylylcyclase (12, 13). Although contro- 
versial, By may also be involved in the direct or indirect 
regulation of ion channels (14-16). 
There is substantial molecular diversity in  both P and y. 
Sequences of four distinct mammalian ,f3 (17-21) and five y 
(22-25) subunits have been reported to date. Although Py 
subunit complexes are, to at least a certain extent, inter- 
changeable among different a subunits, the molecular diver- 
sity of p and y demands  examination of functional signifi- 
cance. However, it  has been very difficult to search for such 
differences, since preparations of Py are often heterogeneous 
and  their composition is poorly defined. Nevertheless, some 
distinctions have been made with purified proteins (26-29). 
In addition,  little is known about the functional  importance 
of the fact that y subunits  are prenylated and processed at  
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23410 G Protein Pr Subunits 
their carboxyl termini  in  a  manner analogous to  that described 
in particular for p21'"" (30, 31). To approach these questions, 
we have synthesized f i  and y subunits singly and in combi- 
nations in Sf9 cells using recombinant baculovirus. Individual 
,By subunit complexes have been purified from this source, 
and we have initiated their characterization. 
MATERIALS  AND  METHODS 
Plasmid Construction-cDNAs encoding G protein PI, P2, yl, y,, 
r2C68S,  and y:j subunits were transferred  to a baculovirus expression 
vector (pVL1392 or pVL1393) as follows. For the P1 subunit (B), a 
3.0-kb cDNA ligated at  the EcoRI site of pBluescript (+) was digested 
with Asp700 and NcoI. The resulting 1.1-kb fragment containing  the 
8, coding sequence was isolated after filling the 3' recessed terminus 
generated by NcoI. This fragment was transferred  to pVL1393 at  the 
SmaI site. For the 0, subunit,  the 1.06-kb ApaI fragment from the 
Okayama and Berg vector containing the P2 cDNA (32) was ligated 
a t  the ApaI site of pGEM-llZf(-).  The  resultingplasmid was digested 
with BamHI  and NotI. The 1.08-kb fragment  containing the  entire 
coding sequence was then transferred to pVL1393 that had been 
digested with the same enzymes. For the yl  subunit (24), the 0.26-kb 
AuaI/Asp7OO fragment  containing the  entire y1 sequence was gener- 
ated from pNG-2-1. This fragment was transferred  to pVL1392 that 
had been digested with SmaI  and NotI. The  termini generated by 
AuaI and NotI were made complementary by partially filling the AvaI 
site with dTTP  and  dCTP  and  the NotI site with dGTP. For the yz 
subunit  (25), a 0.425-kb BglII/EcoRI fragment  containing the  entire 
coding sequence was isolated from a  pBluescript based vector. This 
fragment was transferred to pVL1392 that had been digested with 
the same enzymes. The y,C68S sequence, in which cysteine  68  has 
been replaced by serine (33), was subcloned into pVL1392 as was y2. 
The coding region of the bovine y3 cDNA (23) was prepared by 
polymerase chain  reaction  amplification of reverse transcribed 
mRNA with the introduction of PstI  and XbaI  sites at  the  5'  and 3' 
ends, respectively. This fragment was cloned into pVL1392. 
Cell Culture and Cloning of Recombinant Baculouiruses-Fall ar- 
myworm ovary (Sf9) cells were propagated in IPL-41 medium supple- 
mented with 10% fetal calf serum as described (34). Recombinant 
baculoviruses were generated by cotransfection of Sf9 cells with the 
expression vectors described above and with linearized AcRP23-lacZ 
viral DNA by the lipofection method (35). Positive  viral clones were 
isolated by plaque assay and were identified by their ability to direct 
the expression of the appropriate proteins  as revealed by immuno- 
blotting. 
Gel Electrophoresis and Zmmunoblotting-To resolve the y sub- 
units, SDS-PAGE was carried out in linear gradient gels (10-20% 
acrylamide; acry1amide:bisacrylamide 26:l)  containing 4 M urea. Sam- 
ples were reduced and alkylated  with  N-ethylmaleimide as described 
(36).  In some cases samples were precipitated with 15%  trichloroacetic 
acid and  the pellets washed with cold acetone before reduction and 
alkylation. Gels were either stained with silver (37) or processed for 
immunoblotting as described (38). The following antisera were used 
a t  the indicated dilutions: P-specific, U-49 1:10,000 (38) and affinity- 
purified K-521 1:400 (32); y-specific, affinity-purified NG-1 (23), 
affinity-purified  X-263  (33), and B-53, all at 1:500. B-53  antiserum 
was generated using a  peptide  corresponding to  the  amino-terminal 
17 residues of the bovine y3 sequence. Detection was achieved using 
donkey anti-rabbit IgG F(ab'), conjugated to horseradish peroxidase 
and  the enhanced chemiluminescence detection  system according to 
the manufacturer's  instructions  (Amersham  Corp.). 
Expression of Py Subunits in Sf9 Cells and Cell Fractionation- 
Typically, Sf9 cells (100-250  ml at 2 X 10' cells/ml) were infected at  
a multiplicity of infection of one  for each of the indicated viruses. 
Cells were collected by centrifugation 60 h after infection and were 
resuspended in a  solution  containing 20 mM NaHepes (pH 8.0), 2 mM 
MgCI,, 1 mM EDTA, 2 mM DTT,  and protease  inhibitors' at  a  density 
of 25 X 10 ' cells/ml. After 5 min on ice, cells were homogenized by 
forcing the cell suspension (six times) through a 25-gauge needle 
attached  to a disposable syringe. The lysate was then centrifuged in 
a  TL-100.3  rotor (Beckman)  at 200,000 X g for 15 min at  4 "C. The 
supernatant or cytosolic fraction was removed, and  the crude partic- 
16 pg/ml each 1-1-tosylamido-2-phenylethyl chloromethyl ke- 
tone, l-chloro-3-tosylamido-7-amino-2-heptanone, and  phenylmeth- 
ylsulfonyl fluoride; 3.2 pg/ml each leupeptin and soybean trypsin 
inhibitor;  and 1 pg/ml aprotinin. 
ulate fraction was resuspended in 0.25-0.5 ml of the same buffer. 
Detergent extracts were made by diluting  particulate  fractions to a 
final  protein  concentration of 5 mg/ml and addition of 10% Lubrol 
PX or 20% sodium cholate to final concentrations of 0.6 or 1%, 
respectively. The mixtures were then homogenized by forcing them 
through a 25-gauge needle (six times).  The detergent extracts were 
collected after centrifugation at  200,000 X g for 15 min at  4 "C in a 
with Lubrol PX and 50% with sodium cholate. 
TL-100.3 rotor. Solubilization of total protein approximated 20% 
Purification of Py"Sf9 cells (1 liter) were grown to a  density of 1 
X lo6 cells/ml in  IPL 41 medium supplemented with 1% fetal calf 
serum and lipid concentrate (GIBCO).  Cultures were coinfected with 
the appropriate  recombinant baculoviruses at  a multiplicity of infec- 
tion of 1 for each virus, and cells were collected 60 h after infection. 
Unless otherwise indicated  all  subsequent  manipulations were carried 
out at  4 "C. Preparation of Sf9 cell membranes was carried out 
essentially as described (34). The cells were lysed in 20 mM NaHepes 
(pH 8.0), 1 mM EDTA, 1 mM EGTA,  5 mM MgCl,, 2 mM DTT, 150 
mM NaCI, and protease inhibitors, and  the membrane pellets were 
washed and resuspended in 20 mM NaHepes (pH 8.0), 2 mM MgCI2, 
1 mM EDTA, 2 mM DTT, and protease  inhibitors.  Membranes 
(typically 30 mg) were solubilized in  the same buffer containing 1% 
sodium cholate at  a  protein concentration of 5 mg/ml. Functional By 
complexes were purified by affinity chromatography using a 10-ml 
column of bovine brain Go,,-agarose. Purified bovine brain Go, (20 
mg) was coupled to 10 ml of w-aminobutyl-agarose by the method of 
Sternweis et al. (30). The concentration of Py binding sites on the 
resulting  resin was approximately 0.6 p ~ .  (We have observed, how- 
ever, that  the binding  capacity of the column is lower when crude 
detergent extracts  are loaded.) The resin was packed in a  Pharmacia 
XK-26-20 column fitted with flow adapters  and was used in a  fast 
protein liquid chromatography system. Approximately 6 nmol of By 
activity (determined by support of ADP-ribosylation (see below), 
using purified bovine brain by as a standard) was diluted to 10 ml 
with 20 mM NaHepes (pH 8.0), 400 mM NaCl, 1 mM EDTA, 2 mM 
DTT, 5 p M  GDP (buffer A), and 0.5% Lubrol PX and applied at  a 
rate of 0.3 ml/min to  the Go,,-agarose, which had been equilibrated in 
the same buffer. After washing the column with 20 ml of buffer A 
containing 0.5% Lubrol PX,  the flow  was increased to 3  ml/min and 
the concentration of Lubrol PX in  the wash buffer was reduced to 
0.05% over 20 ml. The resin was washed with 200 ml of buffer A 
containing 0.05% Lubrol PX. Elution was then achieved with 20 mM 
NaHepes (pH 8.0), 400 mM NaCl, 2 mM DTT, 5 p~ GDP, 30 p M  
A1CI3, 20 mM MgCl,, 10 mM NaF (buffer B),  and 0.05% Lubrol PX. 
Fractions (10 ml) were collected at  a rate of 0.3 ml/min. To increase 
the  rate of dissociation of By during the elution, the resin was warmed 
to approximately 15 "C with a  water  jacket. Fractions containing By 
(judged  by SDS-PAGE  and silver stain) from two or three  chromat- 
ographic runs were pooled (100-200 ml) and concentrated in a PM- 
10 Amicon ultrafiltration device to a volume of  10-20 ml. This 
material was loaded onto a  1-ml  hydroxylapatite column previously 
equilibrated with 20 mM NaHepes (pH 8.0), 100 mM NaC1, 2 mM 
DTT,  and 0.05% Lubrol PX.  The column was then washed with 5 ml 
of the same buffer and Py was eluted in 1-ml  fractions with 5 ml of 
the same buffer containing 50 mM potassium  phosphate. Fractions 
containing 07 were pooled and subjected again to chromatography on 
Go,,-agarose. The pooled fractions were concentrated and subse- 
quently adsorbed to hydroxylapatite and eluted as described above. 
The final preparations were diluted appropriately to achieve a Py 
concentration of  0.5 p~ (based  on an Amido Black protein  assay  (39) 
using bovine serum  albumin as  standard)  and a Lubrol PX concen- 
tration of 0.025%. The preparations were stored at -80 "C. The final 
yields varied from 50 to 200 pg of By, depending on the particular 
complex that was synthesized. Endogenous Py from Sf9 cells was 
purified as described above from membranes of cells infected with 
control  (Lac-Z)  virus encoding @-galactosidase. Bovine brain By was 
purified as described by Sternweis et al. (36) and corresponds to a 
pool from the second  heptylamine-Sepharose column in the presence 
of AI3+, M e ,  and F-. Transducin Py was a generous gift of Dr. 
Susanne Mumby. Both bovine brain and transducin By were subjected 
to Go,-agarose chromatography, followed by hydroxylapatite chro- 
matography, as described. 
Partial Purification of Ply2C68S-A cytosolic fraction (10 ml, 2 
mg/ml) from Sf9 cells infected with  recombinant baculoviruses en- 
coding P I  and y2C68S was loaded onto  a  Pharmacia Mono-Q HR 5/5 
column equilibrated with 50 mM Tris-HC1 (pH 8.0), 1 mM EDTA, 
and 2 mM DTT. After washing the column with 5 ml of the same 
buffer, proteins were eluted with a linear gradient of NaCl (0-350 
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 25, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
G Protein P-y Subunits 23411 
mM). Fractions containing 81~2C68S (eluting at  approximately 150 
mM NaC1) were  pooled and concentrated. The amount of By in the 
pool was estimated by quantitative immunoblotting, using purified 
&y2 as  a standard. The expressed protein constituted approximately 
20% of the total protein in the pool. 
Support of ADP-ribosylation and Adenylylcyclase  Assays-The ca- 
pacity of By to support the ADP-ribosylation of  rGi,,l was assessed as 
described, with some modifications (40). The final lipid concentration 
was increased to 1 mM, and purified rGi,, (20 pmol/assay) was  used 
as a  substrate. The use of a high concentration of substrate devoid of 
any endogenous By allowed the reliable quantitation of 50  fmol of By 
activity (1.2 nM final concentration in the assay), even in crude 
detergent extracts. To assay column fractions containing Al"+, M e ,  
and F-, the MgCI, in the reaction mixture was replaced with EDTA 
to yield a final concentration of EDTA that was at  least 1 mM in 
excess of the concentration of  MgC12 contributed by the sample. This 
change has essentially no effect on the kinetics of the reaction (26). 
For adenylylcyclase assays, membranes from Sf9 cells infected with 
recombinant baculoviruses encoding type-I or type-I1 adenylylcyclase 
were prepared as described (12). Purified recombinant Drosophila 
calmodulin and rGan.*  were provided by Dr. Wei-Jen Tang. rGIR.*  was 
activated with GTPyS for 30  min at  30  "C in 20 mM NaHepes (pH 
8.0), 1 mM EDTA, 1 mM DTT, 10 mM MgS04, and 100 p M  GTPyS. 
Free nucleotide was  removed  by  gel filtration. Membranes containing 
type-I or type-I1 adenylylcyclase were incubated with Ca2+/calmodu- 
lin or GTPyS-rG,.., respectively, for 10 min at 30 "C. Aliquots (IO 
pl) were then distributed to tubes  containing the indicated amounts 
of purified Py (10 pl). The reactions were initiated by the addition of 
80 pl of the remaining reaction components (12). After 10 min at  
30 "C, the reactions were terminated and cyclic AMP was quantified 
by the method of Salomon (41). The final concentrations of activators 
were 50 p M  CaCI2 and 100 nM calmodulin for type-I adenylylcyclase 
and 50 nM GTPyS-rG,, for type-I1 adenylylcyclase. 
Gel Filtration Chromatography-Cytosolic fractions and cholate 
extracts of membranes were prepared as described above from Sf9 
cells independently expressing or ~2C68S as well as from cells 
expressing both subunits. Before chromatography, cytosolic fractions 
were adjusted to 1% sodium cholate. Aliquots (200 pl; 0.5-1 mg of 
protein) of samples containing PI (cholate extract), y2C68S (cytosol), 
or 81y2C68S (cytosol) were injected onto a Pharmacia Superose 12 
HR 10/30 gel filtration column that had been equilibrated with 20 
mM NaHepes (pH 8.0), 2 mM MgCI2,  150 mM NaCI, 1 mM EDTA, 2 
mM DTT, and 1% sodium cholate. Proteins were eluted at a  rate of 
0.3 ml/min, and 0.5-ml fractions were collected (starting  2 ml after 
injection of the sample). Aliquots (100 pl) of selected fractions were 
precipitated with 15% trichloroacetic acid, and 25% of each sample 
was subjected to SDS-PAGE and immunoblotting as described above. 
fi  and y subunits were identified with antisera U-49 and X-263, 
respectively. The intensities of bands were quantified with a laser 
densitometer. 
RESULTS 
Expression of G Protein @y Subunits in Sf9 Cells-Concur- 
rent infection of Sf9 cells with recombinant baculoviruses 
encoding the G protein p2 and y2 subunits leads to a substan- 
tial, time-dependent increase in By subunit activity as as- 
sessed by the capacity of detergent extracts of cell membranes 
to  support the ADP-ribosylation of rGial (Fig. 1). No such 
activity is detected when either  subunit is expressed alone or 
when the cells are infected with a control  virus encoding @- 
galactosidase (Lac-Z). The lack of activity when each subunit 
is expressed independently is not due to a failure to synthesize 
the polypeptides, since expression of the  subunits was con- 
firmed by SDS-PAGE and immunoblotting (Fig. 1, inset). It 
thus appears that  this characteristic /3y activity is dependent 
on both  subunits. We have not been successful in attempts  to 
reconstitute activity by mixing detergent extracts from cells 
expressing each subunit independently (data  not shown). 
Little is known about the selectivity of interactions between 
different B and y subunits. However,  by coinfecting Sf9 cells 
with pl- or &-encoding viruses and  either yl, 7 2 ,  or 7 3  viruses 
we have tested the ability of these six combinations to yield 
a complex capable of supporting the ADP-ribosylation of 
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FIG. 1. Expression of B and 7 subunits in Sf9 cells. Cultures 
(100 ml) of Sf9 cells (1 X IO6 cells/ml) were infected at  a multiplicity 
of infection of 1 with control (Lac-Z) virus (V), with recombinant 
baculoviruses encoding G protein p2 (0) or y2 (A) subunits, or with 
both  and y2 viruses (m). A t  the indicated times  after infection, 10- 
ml aliquots were withdrawn and 0.6% Lubrol PX extracts of crude 
particulate fractions were obtained and assayed (0.5 pg of protein) 
for support of ADP-ribosylation activity as described under "Mate- 
rials and Methods." Inset, 20 pg of crude particulate fractions from 
cells collected 72 h  after infection were subjected to SDS-PAGE and 
immunoblotting as described under "Materials and Methods." The 
upper and lower sections of the blot were separated and probed  with 
affinity-purified K-521 and X-263 antisera, respectively. The migra- 
tions of molecular  weight standards and of the and y subunits are 
indicated at  the left and right, respectively. 
rGiol. All combinations  tested led to  the accumulation of such 
activity except that of the retinal y1 subunit with the nonre- 
tinal p2 subunit. As shown in Fig. 2A, ADP-ribosylation 
activity is present  in  detergent extracts of Sf9 cells when y1 
is expressed with the retinal @, subunit. However, no activity 
is detected when y1 is expressed with &. Immunoblot analysis 
of crude particulate  fractions and of detergent  extracts from 
cells infected with Plyl and @2y1 (Fig. 2B)  reveals that all 
subunits are synthesized. For cells expressing and yl, the 
detergent extract contains immunoreactivity for both @ and 
y. In contrast,  little or no O2 immunoreactivity is detected in 
extracts from cells expressing pZ and yl ,  although y can be 
solubilized efficiently. This extraction behavior is similar to 
that observed when the subunits  are expressed alone (data 
not shown). The results suggest that y1 fails to form a func- 
tional complex with p2 under these conditions, although it 
can do so with Dl. For the /3 and y combinations that yield 
functional complexes, we estimate that active @y comprises 
from 0.5 to 2% of the protein  present in  the cholate extract, 
depending on the particular combination. 
Purification of @y Complexes-To perform careful compar- 
isons of the properties of different Py subunit complexes, it 
is necessary to purify each of these  in a functional form. To 
achieve this we have adapted a powerful affinity purification 
scheme based on the immobilized bovine brain Goo-agarose 
matrix originally described by Sternweis et al. (30). This 
method allows the selective purification of @y complexes that 
can associate stably but reversibly with Goa. To minimize 
copurification of endogenous Sf9 cell @y species, extracts were 
prepared under  conditions that do not favor dissociation of 
the endogenous heterotrimeric G proteins. An example of 
preparation of ply2 by  Go,-agarose chromatography is shown 
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FIG. 2. Concurrent expression of y1 with B1 or B2 subunits. 
A,  the indicated amounts of cholate extract protein derived from 
membranes of Sf9 cells  were  assayed  for support of ADP-ribosylation 
activity as described under “Materials and Methods.” Cells were 
infected  with  control  (Lac-Z)  virus (0) or  were infected  concurrently 
with PI and y1 viruses (0) or with 82 and y1 viruses (0). B,  membranes 
(M) (1 pg, upper  panel; 10  pg, lower panel) and cholate extracts ( E )  
(5  pg, both panels) of membranes from Sf9 cells infected with the 
indicated  viruses  were  subjected to SDS-PAGE and immunoblotting 
as described  under  “Materials and Methods.” The upper and lower 
panels were  probed  with affinity-purified  K-521 and NG-1 antisera, 
respectively.  Only the regions of the blot  showing immunoreactivity 
are shown. The amount of membranes  used  in the upper  panel was 
reduced  because  of the large  amount of 0 immunoreactivity. 
- LO&- 10 20 30 40 50 60 70 80 
Fraction Number 
FIG. 3. Purification of Bly2 by  G,-agarose  chromatography. 
An aliquot (1.5 ml, 1.3 mg/ml) of a 1%-cholate extract of membranes 
from Sf9 cells  infected  with @, and y2 viruses  was diluted to 5 ml  with 
buffer A containing 0.5% Lubrol PX and was  added to 5 ml  of Go,- 
agarose.  After a 1-h incubation at 4 “C with  gentle  mixing, the resin 
was packed into a column and drained. The resulting  flowthrough 
was  reapplied  to the column and collected as fraction 1. The column 
was then washed  with 50 ml  of buffer A containing 0.5%  Lubrol  PX 
(fractions 2-1 1 ), followed  by 50 ml of buffer A containing 0.1% Lubrol 
PX (fractions 12-21) and by 65 ml of buffer A containing 0.05% 
Lubrol  PX (fractions 22-35). By was eluted at room temperature with 
buffer B containing 0.05% Lubrol PX, and 1.5-ml fractions were 
collected. The fractions were  assayed  for support of ADP-ribosylation 
activity as described under ”Materials and Methods.” A standard 
curve (using purified bovine brain @y) was used to estimate the 
amount of By in  each fraction. The dashed line indicates the cumu- 
lative amount of @y activity recovered in the elution. In a similar 
experiment  using an equivalent  amount of cholate extract from  cells 
infected with control  (Lac-Z)  virus, the total yield  of By activity in 
the elution was 45 pmol. 
in Fig. 3. Typical recoveries of by activity were in  the range 
of 50-60%. Although substantial  purification  is achieved by 
Go,-agarose chromatography followed by concentration  on a 
hydroxylapatite column, more highly purified preparations 
were obtained  when  the  material was subjected to Go,-agarose 
chromatography a second  time.  Largely purified  preparations 
of /3y from bovine brain  and bovine rod  outer  segments were 
also purified  further by this  method to select for functionally 
active  material.  We  have also purified  small  amounts of ,8r 
from Sf9 cells infected  with a control  virus (Lac-Z). 
The different  preparations of /3y have been compared  by 
SDS-PAGE  and silver staining  and  by  immunoblot  analysis 
using  various selective antisera (Fig. 4). Endogenous Sf9 cell 
Py can be distinguished by the  faster  migration of the insect 
y subunit (Fig. 4A); this  band is not  detected in the other 
preparations purified from Sf9 cells. The mobilities of y 
subunits  are  anomalous  in  this  SDS-PAGE system. Based on 
the predicted molecular  weights of the fully processed yl, 7 2 ,  
and 7 3  subunits of 8500, 7900, and 8300, respectively, the y1 
subunit  should  have  the slowest  mobility; by  contrast,  it has 
the fastest. As expected, the y subunit of transducin comi- 
grates with  the y subunit of the plyl complex, and  they  are 
both poorly stained  with silver. The immunoblotting  results 
shown  in Fig. 4B indicate that the pattern of immunoreactiv- 
ity of /3 subunits is consistent  with the reactivity of U-49 (01- 
specific) and  affinity-purified  K-521(&-  and &reactive) anti- 
97.4 - 
66.2 - 
42.7 - 
31.5 - 
21.5 - 
14.0 - 
B 
u-49 
K-521 
NG-1 
x-263 
553 
1 
FIG. 4. Silver stains and  immunoblots  of  purified By prep- 
jected to SDS-PAGE  as  described  under “Materials and  Methods.” 
arations. Each  of the purified @y preparations (2.5 pmol)  was  sub- 
One of the gels  was stained with  silver (panel A ) .  The migrations  of 
molecular  weight standards and of the B and y subunits  are  indicated 
at the left and right, respectively. y1 Subunits migrate  slightly  faster 
than do y2 and stain poorly  with  silver. Identical gels  were transferred 
to nitrocellulose and probed  with  @-specific antisera U-49 and K-521 
or with  y-specific antisera NG-1, X-263, and B-53,  as  described  under 
“Materials and  Methods.” The areas of immunoreactivity for each 
antiserum  are shown  in panel B. 
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sera.  The Sf9 cell py preparation  reacts only weakly with both 
antisera. The affinity-purified NG-1 antiserum raised against 
a peptide sequence unique to y1 recognizes only the y subunits 
of transducin and ply1. As anticipated, based on the amino 
acid sequence of the peptide used as  the antigen (30), affinity- 
purified  antiserum X-263 reacts with both y2 and y3 subunits. 
Antiserum B-53 recognizes only 7 3 .  None of the antibodies 
recognize the Sf9 cell y polypeptide. Based on silver staining 
and immunoblotting, the bovine brain By preparation is most 
probably composed largely of p1 and y2 subunits. 
Support of ADP-ribosylution by Purified Py Preparatiom- 
ADP-ribosylation of G protein a subunits by pertussis  toxin 
is a sensitive means to monitor  interactions between a and 
By, since the heterotrimeric G protein is the preferred  sub- 
strate for the toxin. As an initial screen to evaluate  potential 
functional differences between individual /?y subunits, we 
have  determined the ability of the purified By preparations to 
support catalytically the ADP-ribosylation of rGial and bovine 
brain When rGial is used as substrate, the rate of ADP- 
ribosylation is substantially different for the different Py 
complexes. Irrespective of the p subunit, the highest rates  are 
observed for the complexes containing y2, while the lowest 
rates are observed with y1 (including transducin By). Inter- 
mediate rates are observed for p1y3 and p2y3. The largest 
difference observed was approximately 6-fold. When bovine 
brain Go,, is used as  substrate (Fig. 5 B ) ,  the  pattern is differ- 
ent,  and  the largest difference in rates is only 2-fold. ADP- 
ribosylation is most rapid  with  transducin by, and  the lowest 
rate is observed with &y3. There is no clear grouping based 
on y subunit composition. It  thus appears that G protein a 
subunits can  discriminate between different complexes. 
However, we have not  yet addressed whether the differences 
observed are due to intrinsic differences between the two CY 
subunits  or  to  the fact that  the recombinant  protein (Giml) is 
rGlul 
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FIG. 5. Support of ADP-ribosylation of rGiml and bovine 
brain G, by purified 67 preparations. The indicated amounts of 
By were assayed for  support of ADP-ribosylation activity as described 
under “Materials and Methods” using 20 pmol  of rGiml (panel A )  or 
bovine brain G,,, (panel B )  as substrates. 
not myristoylated. In addition, although this assay is simple 
technically and very sensitive, it is complex mechanistically 
and does not allow a straightforward  assessment of the rela- 
tive  affinities of a for j3-y (see below). 
Effect of Different By Complexes on Type-I and Type-II 
Adenylylcyclase Activity-Type-I adenylylcyclase is activated 
by either Ca’+/calmodulin or GBm; such activation can be 
partially reversed by Py in a noncompetitive fashion (12). By 
contrast, when type-I1 adenylylcyclase is stimulated by GBa, 
further addition of fly causes a large potentiation of Gsm- 
stimulated activity (12). We examined the ability of the 
different Py complexes to inhibit Ca*+/calmodulin-stimulated 
type-I adenylylcyclase (Fig. 6). All preparations can inhibit 
type-I adenylylcyclase activity. However, plyl and transducin 
Py are approximately 10 and 20 times, respectively, less potent 
than  the  other fly preparations. The difference is thus  attrib- 
utable to  the y subunit. The bovine brain preparation behaves 
essentially as does its recombinant counterpart, ply2. The 
pattern was very similar when we examined the effect of the 
different Py preparations on rG,,.,-stimulated type-I1 adeny- 
lylcyclase (Fig. 7); again, transducin by and plyl are approx- 
imately 10 and 20 times less potent  than  the  other complexes, 
and ply2 is very similar to bovine brain By. 
Effects of Prenylation  on Py Function-We have compared 
the properties of the wild type y2 subunit with those of a 
mutant yz in which the cysteine four amino acid residues 
from the carboxyl terminus has been changed to serine 
(y2C68S). This cysteine residue is the presumed site of pren- 
ylation of y, and  this  mutant protein cannot be prenylated in  
vivo (33, 42). When  both wild type and  mutant y z  subunits 
are coexpressed with pl, ADP-ribosylation activity is detected 
only in detergent extracts of Sf9 cells infected with wild type 
yz (Fig. &I). In a mammalian cell expression system, 
coexpression of  y2C68S with PI causes distribution of to  the 
cytosolic fraction. SDS-PAGE and immunoblot analysis of 
Sf9 cell fractions (Fig. 8C) indicates that  substantial y2 im- 
munoreactivity is found  in the cholate extract of membranes, 
with  little or no reactivity in the cytosolic fraction. By con- 
trast, little or no rzC68S is found in the cholate extract, 
whereas substantial immunoreactivity is present  in the cyto- 
sol. Furthermore, coinfection of yzC68S with P1 leads to a 
[Pr I (M) 
FIG. 6. Inhibition of Ca’+/calmodulin-stimulated type-I ad- 
enylylcyclase by purified fly preparations. Aliquots (10 pg) of 
Sf9 cell membranes containing type-I adenylylcyclase were assayed 
for 10 min in the presence of 100 nM calmodulin, 50 pM CaCl,, and 
the indicated concentrations of the purified preparations of Pr. Values 
are expressed as a percent of the maximal calmodulin-stimulated 
activity in the absence of Py. Data from  duplicate determinations of 
two to four independent experiments are included. The average  basal 
and calmodulin-stimulated activities were 0.4 and 5.1 nmol  of cyclic 
AMP X min” X mg”, respectively. The curues shown are the nonlin- 
ear least-squares fits  to the four  parameter logistic equation Y = (A/ 
(1 + ( C / X ) ’ ) )  + D, and the derived ICsovalues are indicated in the 
inset. 
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40 
3[ 20 1
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FIG. 7. Potentiation of rG,..-stimulated type-I1 adenylyl- 
cyclase activity by purified By preparations. Aliquots (1 pg) of 
Sf9 cell membranes containing type-I1 adenylylcyclase were assayed 
for 10 min in the presence of 50 nM GTP+-rG,.. and the indicated 
concentrations of the different purified By preparations. Data shown 
are the averages of duplicate determinations from a single experiment, 
which is representative of three such experiments. The curues shown 
are the nonlinear least-squares fits to the four parameter logistic 
equation Y = ( A / ( I  + ( C / X ) H ) )  + D, and  the derived ECsovalues are 
indicated in the inset. 
shift in the distribution of B from the cholate extract to  the 
cytosolic fraction. This pattern is in agreement with the 
results obtained in the mammalian system (33). Since most 
of the y2C68S is  located in the Sf9 cell  cytosol, we tested  this 
fraction for support of ADP-ribosylation (Fig. BB). There  is 
no cytosolic activity from  cells expressing either wild type 7 2  
or 72C68S. Distribution of /3 to  the cytosol  when  expressed 
with y2C68S suggests that unprenylated y 2  is  still associated 
with 8. To examine this possibility, we have analyzed the 
behavior of 0 and 72C68S subunits during gel filtration chro- 
matography. When a cytosolic fraction from cells infected 
with p1 and y2C68S viruses is fractionated on  a Superose 12 
gel filtration column, B1 and y2C68S coelute at  a position 
consistent with the formation of a complex  (Fig. 9). Further- 
more, p172C68S elutes before y2C68S, as determined by gel 
filtration of a cytosolic fraction from  cells expressing 72C68S 
alone (Fig. 9). Dl and y2C68S also copurify during anion 
exchange chromatography of a cytosolic fraction from  cells 
expressing both subunits, again consistent with the existence 
of a complex  between the subunits  (data not shown). Taken 
together, these data indicate that prenylation and subsequent 
carboxyl-terminal processing are  not required for interaction 
between /3 and y. 
The failure of BlyzC68S to support ADP-ribosylation of 
rGic,l could  be  due to  a very  low affinity of this complex  for G 
protein (Y subunits or to  the formation of a complex that is 
not a  substrate for ADP-ribosylation by pertussis toxin. We 
thus subjected a cytosolic fraction from  cells  coexpressing 
and y2C68S and  a cholate extract from  cells expressing the 
wild type complex to Go,-agarose chromatography (Fig. 10). 
The wild type complex binds stably to immobilized Go, and 
is eluted when the CY subunit  is activated with Al", MF, and 
F-. In contrast, the mutant complex flows through the col- 
umn. These data indicate that 8172C68S has a much lower 
affinity for the GDP-bound form of Go, than does its wild 
type counterpart. This result also indicates that Go,-agarose 
chromatography selects for By complexes that have been 
properly prenylated. 
Although y subunit prenylation appears to be essential for 
interaction of By with a, this mutant complex might still 
interact productively with effectors such as adenylylcyclase. 
We have therefore examined the ability of partially purified 
P1~2C68S to regulate adenylylcyclase activity (Fig. 11). High 
concentrations of &y2C68S do not inhibit calmodulin-stimu- 
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FIG. 8. Support of ADP-ribosylation by Blyz and B1r2C68S. 
Cytosolic fractions as well as  1%-cholate  extracts from crude partic- 
ulate fractions were obtained from Sf9 cells infected with control 
(Lac-Z) virus (0) or from cells coinfected with 8, and y2 viruses (m) 
or with @ and  r2C68S viruses (0). The indicated amounts of cholate 
extract (panel A )  or cytosolic protein (panel B )  were assayed for 
support of ADP-ribosylation activity as described under "Materials 
and Methods." C, for each infection, cytosolic protein (30 pg, C) and 
cholate-extract protein (20 pg, E )  derived  from an equal number of 
cells were subjected to SDS-PAGE and immunoblotting as described 
under "Materials and Methods." The upper and lower sections of the 
blot were probed with U-49 and affinity-purified X-263 antisera, 
respectively. 
lated type-I adenylylcyclase activity, nor  do they potentiate 
G,-stimulated  type-I1  adenylylcyclase activity. Furthermore, 
the  mutant complex fails to diminish the effects of  wild type 
By when the  mutant is in 100-fold  excess. Thus, it appears 
that y subunit prenylation and/or additional carboxyl-termi- 
nal processing of the protein are not required  for interaction 
between p and y; however, at least certain of these modifica- 
tions are essential for other  important protein-protein inter- 
actions: those between Py and (Y and between By and adeny- 
lylcyclase. 
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FIG. 9. Superose 12 gel filtration chromatography of 
PlyaC68S. A  cytosolic fraction from Sf9 cells expressing p1-y2C68S 
was adjusted to  contain 1% sodium cholate,  and 200 pl (580 pg) of 
this fraction was subjected to gel filtration chromatography as de- 
scribed under “Materials and Methods.” Aliquots (100 pl) of the 
indicated fractions were precipitated with trichloroacetic acid, and 
25% of each  sample was subjected to  SDS-PAGE  and  immunohlotting 
as described under  “Materials  and Methods.” Blots were probed  with 
antiserum U-49 ( B  region) and  affinity-purified  antiserum  X-263 ( y  
region).  Quantitation of band  intensity was  performed with a laser 
densitometer,  and  data  are expressed as percent of the  total  immu- 
noreactivity.  The arrows show the  elution  positions for molecular  size 
standards of the indicated molecular masses (kDa), as well as the 
elution position of p1 and 7 4 6 8 s  when  a 1%-cholate  extract (Dl )  and 
a cytosolic fraction (yrC68S) of Sf9 cells expressing  these  subunits 
individually were run  under  identical  conditions. 
DISCUSSION 
G protein p and y subunits function as a tightly bound 
complex that  is  disrupted  only by denaturants.  The  results 
presented here indicate  that coexpression of both  subunits  is 
required  to  detect  the  activity of the complex. This suggests 
that  the  functional  properties of the complex are  dependent 
on contributions from both  proteins.  Schmidt  and  Neer (43) 
noted  that most /3 subunit  protein becomes  aggregated  when 
translated in uitro, although a monomeric fraction of this 
protein  is capable of forming a  complex when mixed with y 
(also  translated in uitro). We have  not been able  to  reconsti- 
tute by activity by mixing detergent  extracts  from cells ex- 
pressing p and y independently.  Expression of @ by itself  in 
Sf9 cells also appears  to lead to aggregation of the  protein, 
since very little  immunoreactivity  can be extracted  from  such 
membranes. It is possible that p and y adopt an active 
conformation only when they are mutually involved in a 
complex. 
The  ability  to c infect Sf9 cells with baculoviruses  encoding 
different p and y subunits has allowed us to examine the 
selectivity of interaction between these  proteins. Of the  six 
Py combinations  tested,  only  one  appears  not to be allowed. 
The observation that y1 will associate readily with p1 but  not 
with 0. is somewhat surprising, since p1 and p2 are 90% 
identical in their  amino acid  sequence; most of the  changes 
are conservative. However, the fact that y1 and p2 yield 
functional complexes with  other  partners  argues  against  most 
trivial explanations for the phenomenon. It is interesting, 
however, that this particular combination is not likely to 
occur in nature,  since  expression of y1 appears  restricted  to 
photoreceptors, cells in which expression of has not been 
reported and in which p1 is by far the predominant form. 
Although the amino-terminal region of p1 (sequences sur- 
30 t - 1  
Fraction Number 
FIG. 10. G,-agarose chromatography of Blyz and B1yzC68S. 
An aliquot (300 pl, 3 mg/ml) of a 1%-cholate extract of a crude 
particulate  fraction from cells  expressing Slyy (m) or 300 11  (7.3 mg/ 
ml) of a cytosolic fraction  (adjusted  to  contain 1% sodium cholate) 
from  cells  expressing @,yyC68S (0) were diluted to 1 ml with buffer 
A and mixed with separate  1-ml  aliquots of Go,,-agarose. After a 1-h 
incubation a t  4 “C with gentle mixing, the resins were packed into 
columns. The  resulting flowthroughs were reapplied to  the columns 
and collected as fraction 1. The columns were then washed with 4 ml 
of buffer  A containing 0.25% Lubrol PX (fractions 2-S), followed by 
5 ml  of buffer  A  containing0.059;  Luhrol PX (fractions 6-10). Elution 
was initiated by stopping  the column and resuspending the resin in 1 
ml  of buffer €3. After a 30-min incubation at  room temperature with 
gentle  mixing, the  columns were allowed to  drain (fraction I 1  ) and 
were subsequently washed with 9 ml of buffer B (fractions 12-20). 
Aliquots (250 pl) of the indicated fractions were precipitated with 
trichloroacetic  acid, and 25% of each  sample was subjected to  SDS- 
PAGE  and  immunohlotting as described under  “Materials  and  Meth- 
ods.” Dl immunoreactivity was detected with antiserum U-49, and 
data were quantified as described in the legend to Fig. 9. Similar 
results were ohtained when yr immunoreactivity was monitored with 
affinity-purified antiserum X-263. 
FIG. 11. B1yzC68S fails to regulate adenylylcyclase activity. 
Sf9 cell membranes  containing  type-I (panel A )  or t-ype-I1 (panel R )  
adenylylcyclase were assayed as described in the legends of Figs. 6 
and 7 in  the  absence or presence of activators (50 p M  Ca& 100 nM 
calmodulin for type I; 50 nM GTPyS-rG,,.., for type 11) and Py (1 nM 
B,y?; 100 nM @,-yyC68S), as indicated. 
rounding Cys’”) has been proposed to  interact with y1 (44), 
the  amino acid sequence surrounding  this residue is nearly 
identical in p, and (3’. Very subtle differences in primary 
sequence or  as  yet  unidentified  post-translational modifica- 
tions may be responsible  for such  subunit selectivity. It will 
be interesting to extend these observations to other more 
divergent forms of /3 and y to  determine how much of the 
potential  combinatorial diversity is actually available. 
The  substantial levels of expression of functional Py com- 
plexes in this system have provided us with a source of 
material of defined  composition. Furthermore, purification of 
Py complexes by subunit-exchange chromatography on a  ma- 
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23416 G Protein ,By Subunits 
trix of Go,-agarose permits valid comparison between the 
different complexes, since the material purified in this fashion 
is functional, at  least  in its ability to  interact with Goa. 
Analysis of the  rates of &-dependent ADP-ribosylation of 
two different a subunits  indicates that a single a is capable 
of distinguishing between different species of By. This is most 
notable in the case of rGial. When this a subunit is used as 
substrate, preference for individual forms of /3y appears  at- 
tributable to y. Previous studies have failed to reveal differ- 
ences in the capacity of different Py complexes to support 
ADP-ribosylation of G  protein (Y subunits (26, 29). Gi and Go 
a subunits  are myristoylated at  their amino  termini, and  this 
modification increases affinity for Py (45). The lack of this 
modification of the Escherichia coli-derived rGial subunit 
could accentuate differences in the interaction of this a sub- 
unit with individual forms of &. The overall rate of the ADP- 
ribosylation reaction is determined  in this assay, and  it is not 
possible to derive estimates of affinity of a for Py based solely 
on these data. Py acts catalytically in this reaction and is 
present in substoichiometric amounts. Thus,  the  rate of ADP- 
ribosylation reflects the ability of By to recycle between G 
protein a subunits. It is therefore possible that a high rate of 
ADP-ribosylation might reflect a higher rate of dissociation 
of by from a, allowing it to recycle more rapidly. Direct 
estimates of the affinity of a for Py can be made by determi- 
nation of the concentration of @y required to slow dissociation 
of GDP from a at appropriately low concentrations of the 
protein reactants. 
We have also compared the ability of the different /3y 
complexes to modulate adenylylcyclase activity, where the 
effect of ,f3y is dependent  on the type of enzyme utilized (12). 
There are  quantitative differences in the ability of different 
By subunits to regulate adenylylcyclases; plyl is approxi- 
mately 10-fold less potent  than  the  other complexes tested. 
Our results are consistent with previous observations that 
transducin Py is less potent  than  brain By in  inhibiting  type- 
I adenylylcyclase (12) or brain adenylylcyclase activity in a 
reconstituted system (27). The differences observed are at- 
tributable to y. One major difference between y1 and  the  other 
y subunits  tested is the isoprenoid used to modify the carboxyl 
terminus; y1 is farnesylated, whereas y 2  and 7 3  are predicted 
to be geranylgeranylated. Although we have not  yet analyzed 
the type of modification carried out by Sf9 cells on G  protein 
y subunits,  these cells do  modify p21'"" appropriately  with  a 
farnesyl group (46). It is possible, then, that the type of 
isoprenoid might be an  important  determinant of the potency 
of a /3y complex in  these assays. It must be noted, however, 
that  the amino acid sequence of y1 is substantially  different 
from those of the more closely related 7 2  and 7 3  polypeptides. 
Further experimentation will be necessary to delineate the 
relative contributions of the polypeptides and the type of 
isoprenoid to  the properties of these complexes. 
In  the assays described here, most of the functional differ- 
ences can be attributed to the y subunits. It seems likely, 
however, that functional differences due to p may be revealed 
when  interactions of Py with other components of the signal- 
ing system (e.g. receptors or  other effectors) are examined or 
when a more extensive group of p subunits is examined. In 
this respect, Law et al. (47) have suggested that brain so- 
matostatin receptors associate preferentially with complexes 
containing Bl. It  will also be of interest  to examine the effects 
of individual /3y complexes on phosphoinositide-specific phos- 
pholipases. Complex effects of By have been observed on 
receptor- and guanine nucleotide-sensitive phosphoinositide 
hydrolysis in turkey  erythrocyte membranes (48). 
The carboxyl-terminal posttranslational modifications of G 
protein y subunits  are  important  determinants of the subcel- 
lular location of By (33, 42). The functional consequences of 
prenylation and carboxymethylation are now being addressed. 
Carboxymethylation of y occurs after prenylation and prote- 
olytic removal of the last 3 amino acid residues (31). The 
mutation examined here (C68S) presumably blocks all of 
these steps. Blockade of carboxyl-terminal processing of y 
does not appear to impair its ability to associate with /3. 
However, the resulting complex is inactive in all other assays. 
The inability of this  mutant complex to compete with the 
wild type analog further indicates that  the COOH-terminal 
modifications are  essential for high affinity  interactions of ,8y 
with both a subunits and adenylylcyclases. The data pre- 
sented here are  consistent with reports  indicating that both 
prenylation and carboxymethylation enhance the ability of 
transducin Py to facilitate rhodopsin-catalyzed binding of 
guanine nucleotides to transducin a (49, 50) and extend the 
observations to include effectors like adenylylcyclase. To- 
gether,  these observations support the hypothesis that lipid 
modifications of proteins are  important  determinants of pro- 
tein-protein interactions, and these interactions may well 
underlie the effects of lipid modification on subcellular local- 
ization. 
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